QRG Capital Management Inc. Trims Stock Position in HCA Healthcare, Inc. $HCA

QRG Capital Management Inc. trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,220 shares of the company’s stock after selling 80,483 shares during the period. QRG Capital Management Inc.’s holdings in HCA Healthcare were worth $29,928,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of HCA. Norges Bank acquired a new position in HCA Healthcare in the 2nd quarter worth about $1,152,408,000. Pacer Advisors Inc. increased its holdings in HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Viking Global Investors LP increased its stake in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of HCA Healthcare during the second quarter valued at approximately $109,337,000. Finally, Metropolis Capital Ltd lifted its holdings in HCA Healthcare by 76.6% in the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock valued at $231,020,000 after purchasing an additional 261,592 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. UBS Group raised their target price on HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Oppenheimer lifted their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Finally, Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research note on Monday, December 15th. Fifteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $487.00.

HCA Healthcare Trading Down 3.0%

Shares of NYSE HCA opened at $469.08 on Friday. The stock has a market capitalization of $107.04 billion, a PE ratio of 18.13, a PEG ratio of 1.33 and a beta of 1.36. The stock has a fifty day simple moving average of $480.49 and a 200-day simple moving average of $430.45. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 29th. Shareholders of record on Monday, December 15th were issued a dividend of $0.72 per share. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 11.13%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Leerink Partners raised its price target on HCA to $507 and kept an “outperform” rating, signaling analyst confidence in HCA’s earnings trajectory and providing a near-term valuation upside catalyst. Leerink Partners lifts price target on HCA Healthcare to $507
• Positive Sentiment: HCA plans to operate 81 freestanding emergency departments in Florida by the end of Q1, reflecting measurable expansion of outpatient / ED capacity that can drive admissions and higher-margin volumes. HCA to have 81 freestanding EDs in Florida by end of Q1
• Positive Sentiment: Regional partnership expansion in Tennessee positions HCA for market share and referral network growth in a fast-growing region. These deals support medium-term revenue expansion without full hospital acquisitions. Tennessee systems to deepen partnership as HCA eyes growth in region
• Neutral Sentiment: HCA promoted Erica Rossitto to chief nurse executive (effective Feb. 1), strengthening nursing leadership for HCA’s 100,000+ nurses — governance/operational news that supports execution but is not an immediate earnings driver. HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
• Neutral Sentiment: Local executive moves (interim chief nurse at an HCA Missouri hospital and other chief nursing appointments) are operational-level items with limited near-term market impact. HCA Missouri hospital names interim chief nurse
• Neutral Sentiment: Third-party health-tech and regional care updates (Medical City Plano CFO change, Memorial Health CT adoption) mentioned in the newsfeed are industry context but not direct HCA drivers. Healthcare Briefs: Medical City Plano’s New CFO and Cariloop’s Partnership With Raymond James
• Negative Sentiment: L1 Capital trimmed its HCA position, citing share-price appreciation; portfolio selling from a notable fund can create near-term supply pressure and contribute to today’s down move. L1 Capital Trimmed HCA Healthcare Due to Share Price Appreciation

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.